The Scientific and Research Team at Sigilon Therapeutics focuses on developing and optimizing immune-protected, engineered human cells to restore normal physiological functions in a variety of chronic diseases. This team conducts cutting-edge research, develops bioanalytical assays, manages preclinical studies, and ensures efficient lab operations to advance Sigilon's innovative cell therapies from discovery through development stages.
View all